Polyvinyl Alcohol Hydrogel Hemiarthroplasty of First Metatarsophalangeal Joint Hallux Rigidus: Single Surgeon Five-Year Experience
| Autor: | Amanda N. Fletcher MD, MS, Aman Chopra BA, Albert T. Anastasio MD, Naji S. Madi MD, Selene G. Parekh MD, MBA |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Foot & Ankle Orthopaedics, Vol 7 (2022) |
| Druh dokumentu: | article |
| ISSN: | 2473-0114 24730114 |
| DOI: | 10.1177/2473011421S00662 |
| Popis: | Category: Midfoot/Forefoot Introduction/Purpose: Hallux rigidus (HR) is the most common arthritic condition of a foot with a prevalence of up to 45% in people aged >75 years-old. First metatarsophalangeal joint (MTPJ) arthrodesis has been the historical gold standard treatment for late-stage HR. Polyvinyl alcohol (PVA) hydrogel implants have similar biomechanical properties as native cartilage, and thus have gained popularity as a joint-sparing technique that provides preservation of MTPJ motion. Initial literature demonstrated pain relief and functional outcomes equivalent to first MTPJ arthrodesis and excellent five-year survivorship. However, recent studies report variable failure rates on PVA hydrogel implants for HR. The purpose of this study was to report the five-year experience and outcomes of PVA hydrogel implants for the treatment of HR performed by a single surgeon. Methods: Electronic health records were queried from August 2016 to August 2021 for patients who underwent primary PVA hydrogel implant hemiarthroplasty (Cartiva Synthetic Cartilage Implant; Cartiva Inc, Alpharetta, GA) for symptomatic late-stage HR. All patients were treated by a single foot and ankle fellowship trained orthopaedic surgeon. A minimum of six months follow- up was required. Patient demographics and perioperative data were collected. Preoperative and postoperative range of motion, visual analog scale (VAS) pain scores, and radiographs were evaluated. Complications and the overall implant survivorship were reported. A Kaplan-Meier analysis was used to evaluate implant survival. Descriptive and univariate statistics were used to analyze data. A total of 196 primary PVA hydrogel implant procedures were performed of which 146 had a minimum six-month follow-up and were included. The mean follow-up was 14.5 (+- 11.9) months. Results: The majority of patients were female (n=103, 70.5%) with a mean age of 58.1 (+-10.1) years-old, BMI of 27.3 (+-5.2) Kg/m2, and an ASA score < 3 (n=131, 89.7%). The majority of patients had stage II or III disease (n=115, 78.8%). Patients experienced significant improvement in VAS (p |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|